Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Alligator Bioscience AB ( (SE:ATORX) ) is now available.
Alligator Bioscience AB announced the final outcome of its TO 12 warrant exercise, achieving a 71% exercise rate, resulting in the subscription of nearly 14 million new shares. To reach an 85% exercise rate, the company will execute top guarantee commitments, raising approximately SEK 61.5 million, which positions them well for further development and a pivotal Phase 3 trial.
More about Alligator Bioscience AB
Alligator Bioscience AB operates in the biotechnology industry, focusing on developing immunotherapies for cancer treatment. The company is particularly invested in advancing mitazalimab, a potential breakthrough therapy for metastatic pancreatic cancer.
Average Trading Volume: 246,581
Current Market Cap: SEK71M
See more data about ATORX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue